FindTrial
Sign In

The effect of Tranexamic Acid in decreasing of bleeding in patients undergoing Functional Endoscopic Sinus Surgery.

The effect of Tranexamic Acid in decreasing of intraoperative bleeding and need for deliberate hypotension in patients undergoing Functional Endoscopic Sinus Surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012111411455N1
Enrollment
66
Registered
2013-03-17
Start date
2012-05-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleeding. Haemorrhage and haematoma complicating a procedure, not elsewhere classified

Interventions

Intervention 1: In intervention group 33 patients 10 mg/kg tranexamic acid in 50 cc normal salin infuse within 15 minute . Intervention 2: In control group 33 patients 50cc normal salin infuse within
Treatment - Drugs
In intervention group 33 patients 10 mg/kg tranexamic acid in 50 cc normal salin infuse within 15 minute .
In control group 33 patients 50cc normal salin infuse within 15 minute.

Sponsors

Ahvaz (Jondishapour) University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:16_40 years olds ASA class1 with crhonic sinusitis canditate for surgery. Exclusion criteria:Pregnancy ; anticoagulant therapy at recent 3 mounts ; patients with coagulopathy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Intraoperative bleeding. Timepoint: During the surgery. Method of measurement: Number of gases and soaked blood into the suction by miili liter.—

Secondary

MeasureTime frame
Intraoperative blood pressure. Timepoint: Every 15 minute. Method of measurement: Automated sphygmomanometer by mmhg.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamidreza Deylamani

Imam Khomini hospital

deylamani.h@ajums.ac.ir+98 61 1222 0168

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026